Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 94
Filter
2.
Med Mol Morphol ; 56(3): 217-224, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37129713

ABSTRACT

Poorly differentiated adenosquamous carcinoma (glassy cell carcinoma) of the cervix is extremely rare, accounting for 1-2% of all cervical cancers. Herein, we report a case with coexistent poorly differentiated adenosquamous carcinoma (glassy cell carcinoma), "usual-type" adenocarcinoma, and squamous cell carcinoma in situ of the cervix. A female patient in her 60 s was referred to our hospital and diagnosed with poorly differentiated adenosquamous carcinoma based on cervical cytology and biopsy. The tumor was classified as clinical stage IB1 cervical cancer following magnetic resonance imaging; radical hysterectomy was performed. Histopathological examination revealed poorly differentiated adenosquamous carcinoma (glassy cell carcinoma), usual-type adenocarcinoma, and squamous cell carcinoma in situ, all coexisting. All carcinoma regions showed identical sizes to high-risk human papillomavirus (HPV) in fragment analysis. The patient is currently alive, without evidence of recurrence, 31 months post surgery. In this case, three different carcinomas coexisted. Fragment analysis of the patient's HPV status suggested that all carcinomas were related to an infection with the same high-risk HPV type. To determine the precise mechanism of tumor development, i.e., whether the tumors were of the mixed or collision type, further studies are needed, including clonal analysis for the loss of heterozygosity pattern.


Subject(s)
Adenocarcinoma , Carcinoma, Adenosquamous , Carcinoma, Squamous Cell , Papillomavirus Infections , Uterine Cervical Neoplasms , Female , Humans , Adenocarcinoma/diagnosis , Adenocarcinoma/surgery , Carcinoma, Adenosquamous/diagnosis , Carcinoma, Adenosquamous/surgery , Carcinoma, Adenosquamous/complications , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/surgery , Cervix Uteri/surgery , Cervix Uteri/pathology , Papillomavirus Infections/diagnosis , Papillomavirus Infections/complications , Papillomavirus Infections/pathology , Uterine Cervical Neoplasms/diagnosis , Uterine Cervical Neoplasms/surgery , Aged
3.
J Pharm Sci ; 111(10): 2745-2757, 2022 10.
Article in English | MEDLINE | ID: mdl-35839866

ABSTRACT

In this study, we conducted a collaborative study on the classification between silicone oil droplets and protein particles detected using the flow imaging (FI) method toward proposing a standardized classifier/model. We compared four approaches, including a classification filter composed of particle characteristic parameters, principal component analysis, decision tree, and convolutional neural network in the performance of the developed classifier/model. Finally, the points to be considered were summarized for measurement using the FI method, and for establishing the classifier/model using machine learning to differentiate silicone oil droplets and protein particles.


Subject(s)
Silicone Oils , Silicones , Particle Size , Proteins
4.
Article in English | MEDLINE | ID: mdl-35682447

ABSTRACT

We propose a new compartment model of COVID-19 spread, the broken-link model, which includes the effect from unconnected infectious links of the transmission. The traditional SIR-type epidemic models are widely used to analyze the spread status, and the models show the exponential growth of the number of infected people. However, even in the early stage of the spread, it is proven by the actual data that the exponential growth did not occur all over the world. We presume this is caused by the suppression of secondary and higher-order transmissions of COVID-19. We find that the proposed broken-link model quantitatively describes the mechanism of this suppression, which leads to the shape of epicurves of confirmed cases are governed by the probability of unconnected infectious links, and the magnitudes of the cases are proportional to expR0 in each infectious surge generated by a virus of the basic reproduction number R0, and is consistent with the actual data.


Subject(s)
COVID-19 , Epidemics , Basic Reproduction Number , Humans , Models, Statistical , SARS-CoV-2
5.
J Infect Chemother ; 28(5): 684-689, 2022 May.
Article in English | MEDLINE | ID: mdl-35190255

ABSTRACT

INTRODUCTION: Staphylococcus aureus colonizes rough regions of the skin of the hand. Healing of S. aureus-mediated wounds is promoted by the application of RNA III inhibiting peptide, which inhibits the production of S. aureus virulence factors, including δ-toxin. Herein, we investigated the level of hand-skin roughness in healthcare professionals after they used an alcohol-based hand rub containing polyoxyethylene lauryl ether (formulation E), which inhibits S. aureus δ-toxin production. METHODS: The inhibition rate of S. aureus δ-toxin production by hand rubs, including formulation E, was calculated by quantifying S. aureus δ-toxin concentration in culture medium using high-performance liquid chromatography. Healthcare professionals used formulations E or S (reference alcohol-based hand rub) for 4 weeks. The surface evaluation of the scaliness (SEsc) value was used as an indicator of hand skin roughness. The ΔSEsc value was calculated by subtracting the SEsc value before using the alcohol-based hand rub from the SEsc value 4 weeks after use. RESULTS: The inhibition rates of S. aureus δ-toxin production by formulations E and S were 43% and 10%, respectively. Formulation E significantly reduced ΔSEsc. The difference in ΔSEsc values after using formulations E and S was significant. CONCLUSIONS: The inhibitory effect on S. aureus δ-toxin production was higher with formulation E than with formulation S. Compared to formulations S, formulation E was effective at reducing scaliness and alleviating hand-skin roughness. Furthermore, the inhibitory effect of formulation E on S. aureus δ-toxin production could be associated with a reduction in scaliness and alleviation of hand-skin roughness.


Subject(s)
Hand , Staphylococcus aureus , Ethanol/pharmacology , Hand Disinfection/methods , Humans , Skin
6.
Anal Sci ; 37(12): 1815-1819, 2021 Dec 10.
Article in English | MEDLINE | ID: mdl-34148922

ABSTRACT

This study aims to provide a simple way to identify the possibility of tetrabromobisphenol A (TBBPA) present in polymers without the need for complicated separation with expensive equipment. Since the presence of phenolic hydroxyl groups is known to be identifiable by the reduction of Fe3+ to Fe2+ in a ferric coloring reagent, the possibility of TBBPA being present in a polymer can be screened by a photometric measurement. A mixed solution of iron(III) nitrate and potassium hexacyanide(III) acid was used as a ferric coloring reagent. With this method, the concentration of TBBPA can be estimated from the photometric absorbance corresponding to the depth of the blue color produced by reduction of the ferric reagent in the presence of Fe(NO3)3. The limit of detection (LOD) was determined to be approximately 2 mg/kg using the Student's t-test (99% confidence), and a reproducibility of approximately 3% was determined by the relative standard deviation (RSD) from measurements of calibration samples (n = 7). Furthermore, TBBPA in actual polymer samples was screened without the need for any complex processing steps. Because this colorimetric method measures TBBPA by detecting phenolic groups, it may overestimate the TBBPA concentration in the presence of other similar phenolic substances. Nonetheless, this simple colorimetric method should help to quickly identify the presence of TBBPA in various polymers.


Subject(s)
Iron , Nitrates , Colorimetry , Ferrocyanides , Humans , Indicators and Reagents , Polybrominated Biphenyls , Reproducibility of Results
7.
J Pharm Sci ; 110(2): 898-904, 2021 02.
Article in English | MEDLINE | ID: mdl-33164810

ABSTRACT

The pathogenic bacterium Staphylococcus aureus can penetrate host cells. However, intracellular S. aureus is not considered during antimicrobial agent selection in clinical chemotherapy because of the lack of information about drug transportability into cells in vivo. We focused on agents used to treat methicillin-resistant S. aureus (MRSA) (vancomycin, arbekacin, linezolid, and daptomycin) and indirectly assessed the drug levels in intracellular compartment using plasma, tissue homogenates, and interstitial fluid (ISF) samples from the skin of rats using the microneedle array technique. Lower drug levels were observed in the ISF than in the plasma for daptomycin but extracellular and intracellular drug levels were comparable. In contrast, vancomycin, arbekacin, and linezolid showed higher concentrations in the ISF than in the plasma. Intracellular transport was estimated only for arbekacin. Stasis of vancomycin in the ISF was also observed. These results suggest that both low vancomycin exposure against intracellular S. aureus infection and long-term subinhibitory drug levels in the ISF contribute to the failure of treatment and emergence of antibiotic resistance. Based on its pharmacokinetic characteristics in niche extravascular tissue spaces, arbekacin may be suitable for achieving sufficient clinical outcomes for MRSA infection because the drug is widely distributed in extracellular and intracellular compartments.


Subject(s)
Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections , Animals , Anti-Bacterial Agents/pharmacology , Microbial Sensitivity Tests , Rats , Staphylococcal Infections/drug therapy , Staphylococcus aureus , Vancomycin/pharmacology
8.
Article in English | MEDLINE | ID: mdl-32512534

ABSTRACT

Various chromatographic techniques, combined with mass spectrometry, have been developed for the analysis of impurities in oligonucleotide drugs, but those methods have generally been less focused on possible phosphomonoester-type compounds. Here, we introduce a simple method for separating terminally phosphorylated impurities from parent oligonucleotides by using a phosphate-affinity micropipette tip (Phos-tag tip). All steps for the phosphate-affinity separation (binding, washing, and elution) are conducted in aqueous buffers at neutral pH. The entire separation protocol requires less than 30 min per sample. In practical examples, we demonstrated that phosphorylated impurities in natural-type and chemically modified oligonucleotides can be efficiently separated by the Phos-tag tip method and subsequently characterized by using ion-pairing reversed-phase liquid chromatography mass spectrometry (IP-RPLC-MS). Thus, a combination of the Phos-tag tip method and IP-RPLC-MS is useful for characterizing and identifying phosphomonoester-type impurities in oligonucleotide drugs.

9.
Diagnostics (Basel) ; 9(1)2019 Mar 07.
Article in English | MEDLINE | ID: mdl-30866585

ABSTRACT

It has been reported that endoscopic retrograde cholangiopancreatography (ERCP) is of value in evaluating precise pancreatograms of the pancreatic duct (PD). Recently, institutions have tended to perform magnetic resonance cholangiopancreatography (MRCP) for the diagnosis of PD due to post-ERCP pancreatitis (PEP). In small pancreatic cancer (PC), including PC in situ (PCIS) which is undetectable on cross sectional images, endoscopic ultrasonography (EUS) and MRCP serve important roles in detecting local irregular stenosis of the PD or small cystic lesions. Subsequently, ERCP and associated serial pancreatic juice aspiration cytologic examination (SPACE) obtained by endoscopic nasopancreatic drainage (ENPD) may be useful in the diagnosis of very early-stage PC. Further prospective multicenter studies are required to establish a standard method of SPACE for the early diagnosis of PC.

10.
J Atheroscler Thromb ; 26(6): 573-581, 2019 Jun 01.
Article in English | MEDLINE | ID: mdl-30518729

ABSTRACT

AIM: Betatrophin, a recently identified circulating adipokine, affects lipid and glucose metabolism. However, association between plasma betatrophin levels and atherosclerotic diseases, such as coronary artery disease (CAD) and peripheral artery disease (PAD), has not been elucidated. METHODS: We investigated plasma betatrophin levels in 457 patients undergoing elective coronary angiography who also had ankle-brachial index (ABI) test for PAD screening. RESULTS: Of the 457 study patients, CAD was present in 241 patients (53%) (1-vessel [1-VD], n=99; 2-vessel [2-VD], n=71; 3-vessel disease [3-VD], n=71). Compared to 216 patients without CAD, 241 with CAD had higher betatrophin levels (median 1120 vs. 909 pg/mL, p<0.001). A stepwise increase in betatrophin levels was found depending on the number of >50% stenotic coronary vessels: 909 in CAD(-), 962 in 1-VD, 1097 in 2-VD, and 1393 pg/ml in 3-VD (p<0.001). Betatrophin levels correlated with the number of >25% stenotic segments (r=0.24, p<0.001). PAD (ABI<0.9) was found in 41 patients (9%). Plasma betatrophin levels were also significantly higher in 41 patients with PAD than in 416 without PAD (1354 vs. 981 pg/mL, p<0.001). In the multivariate analysis, betatrophin levels were not a factor for CAD, but they were a significant factor for 3-VD and PAD independent of atherosclerotic risk factors. The odds ratios for 3-VD and PAD were 1.06 (95%CI=1.01-1.11) and 1.07 (95%CI=1.01-1.13) for a 100-pg/mL increase in betatrophin levels, respectively (p<0.05). CONCLUSION: Plasma betatrophin levels were associated with the presence and severity of CAD and PAD, suggesting betatrophin has a role in atherosclerosis.


Subject(s)
Angiopoietin-like Proteins/blood , Biomarkers/blood , Coronary Artery Disease/blood , Peptide Hormones/blood , Peripheral Arterial Disease/blood , Aged , Angiopoietin-Like Protein 8 , Coronary Angiography , Coronary Artery Disease/complications , Coronary Artery Disease/pathology , Cross-Sectional Studies , Female , Follow-Up Studies , Humans , Male , Peripheral Arterial Disease/complications , Peripheral Arterial Disease/pathology , Prognosis , Risk Factors
11.
Stroke ; 49(9): 2230-2232, 2018 09.
Article in English | MEDLINE | ID: mdl-30354985

ABSTRACT

Background and Purpose- Heme oxygenase-1 (HO-1) catalyzes the oxidation of heme to generate carbon monoxide, biliverdin, and iron. Because these products have antiatherogenic properties, HO-1 may play a protective role against atherosclerosis. However, plasma HO-1 levels in patients with carotid atherosclerosis have not been reported. Methods- We investigated plasma HO-1 levels by ELISA in 136 subjects (age, 66±9 years) undergoing carotid ultrasonography. Results- Of the 136 study subjects, carotid plaque was found in 61 subjects (45%). Compared with 75 subjects without plaque, 61 with plaque were older and predominantly male ( P<0.05). Plasma HO-1 levels were higher in subjects with plaque than in those without plaque (median, 0.56 versus 0.44 ng/mL; P<0.05). The percentage of subjects with HO-1 level >0.50 ng/mL was higher in subjects with plaque than without plaque (66% versus 44%; P<0.025). In multivariate analysis, HO-1 level was a significant factor for carotid plaque independent of atherosclerotic risk factors. Odds ratio for plaque was 2.33 (95% CI, 1.15-4.75) for HO-1 level >0.50 ng/mL. Conclusions- Plasma HO-1 levels were high in subjects with carotid plaques, probably reflecting a protective response against carotid atherosclerosis.


Subject(s)
Carotid Artery Diseases/blood , Heme Oxygenase-1/blood , Plaque, Atherosclerotic/blood , Aged , Carotid Artery Diseases/diagnostic imaging , Case-Control Studies , Female , Humans , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Plaque, Atherosclerotic/diagnostic imaging , Ultrasonography
12.
Dis Markers ; 2018: 6138124, 2018.
Article in English | MEDLINE | ID: mdl-30159103

ABSTRACT

AIMS: Heme oxygenase-1 (HO-1) is an intracellular enzyme that catalyzes the oxidation of heme to generate CO, biliverdin, and iron. Since these products have antiatherogenic properties, HO-1 may play a protective role against the progression of atherosclerosis. However, plasma HO-1 levels in patients with atherosclerotic diseases, such as coronary artery disease (CAD) and peripheral artery disease (PAD), have not been clarified yet. METHODS: We investigated plasma HO-1 levels by ELISA in 410 consecutive patients undergoing elective coronary angiography who also had an ankle-brachial index (ABI) test for PAD screening. RESULTS: Of the 410 study patients, CAD was present in 225 patients (55%) (1-vessel (1-VD), n = 91; 2-vessel (2-VD), n = 66; 3-vessel disease (3-VD), n = 68). PAD (ABI < 0.9) was found in 36 (9%) patients. Plasma HO-1 levels did not differ between 225 patients with CAD and 185 without CAD (median 0.44 versus 0.35 ng/mL), but they were significantly lower in 36 patients with PAD than in 374 without PAD (0.27 versus 0.41 ng/mL, P < 0.02). After excluding the 36 patients with PAD, HO-1 levels were significantly higher in 192 patients with CAD than in 182 without CAD (0.45 versus 0.35 ng/mL, P < 0.05). HO-1 levels in 4 groups of CAD(-), 1-VD, 2-VD, and 3-VD were 0.35, 0.49, 0.44, and 0.44 ng/mL, respectively, and were highest in 1-VD (P < 0.05). In the multivariate analysis, HO-1 levels were inversely associated with PAD, whereas they were also associated with CAD. The odds ratios for PAD and CAD were 2.12 (95% CI = 1.03-4.37) and 0.65 (95% CI = 0.42-0.99) for the HO-1 level of <0.35 ng/mL, respectively. CONCLUSIONS: Plasma HO-1 levels were found to be low in patients with PAD, in contrast to high levels in patients with CAD.


Subject(s)
Coronary Artery Disease/diagnostic imaging , Heme Oxygenase-1/blood , Peripheral Arterial Disease/diagnostic imaging , Aged , Aged, 80 and over , Ankle Brachial Index , Coronary Angiography , Coronary Artery Disease/blood , Coronary Artery Disease/enzymology , Disease Progression , Female , Humans , Male , Middle Aged , Odds Ratio , Peripheral Arterial Disease/blood , Peripheral Arterial Disease/enzymology
13.
Phys Rev Lett ; 120(21): 212001, 2018 May 25.
Article in English | MEDLINE | ID: mdl-29883161

ABSTRACT

The ΩΩ system in the ^{1}S_{0} channel (the most strange dibaryon) is studied on the basis of the (2+1)-flavor lattice QCD simulations with a large volume (8.1 fm)^{3} and nearly physical pion mass m_{π}≃146 MeV at a lattice spacing of a≃0.0846 fm. We show that lattice QCD data analysis by the HAL QCD method leads to the scattering length a_{0}=4.6(6)(_{-0.5}^{+1.2}) fm, the effective range r_{eff}=1.27(3)(_{-0.03}^{+0.06}) fm, and the binding energy B_{ΩΩ}=1.6(6)(_{-0.6}^{+0.7}) MeV. These results indicate that the ΩΩ system has an overall attraction and is located near the unitary regime. Such a system can be best searched experimentally by the pair-momentum correlation in relativistic heavy-ion collisions.

14.
Cell ; 168(3): 527-541.e29, 2017 01 26.
Article in English | MEDLINE | ID: mdl-28111073

ABSTRACT

Advances in the synthesis and screening of small-molecule libraries have accelerated the discovery of chemical probes for studying biological processes. Still, only a small fraction of the human proteome has chemical ligands. Here, we describe a platform that marries fragment-based ligand discovery with quantitative chemical proteomics to map thousands of reversible small molecule-protein interactions directly in human cells, many of which can be site-specifically determined. We show that fragment hits can be advanced to furnish selective ligands that affect the activity of proteins heretofore lacking chemical probes. We further combine fragment-based chemical proteomics with phenotypic screening to identify small molecules that promote adipocyte differentiation by engaging the poorly characterized membrane protein PGRMC2. Fragment-based screening in human cells thus provides an extensive proteome-wide map of protein ligandability and facilitates the coordinated discovery of bioactive small molecules and their molecular targets.


Subject(s)
Drug Discovery/methods , Proteomics/methods , Adipocytes/cytology , Cell Differentiation , Crystallography, X-Ray , High-Throughput Screening Assays , Humans , Hydrolases/chemistry , Ligands , Membrane Proteins/antagonists & inhibitors , Oxidoreductases/chemistry , Protein Binding , Receptors, Progesterone/antagonists & inhibitors , Small Molecule Libraries
15.
Phys Rev Lett ; 117(24): 242001, 2016 Dec 09.
Article in English | MEDLINE | ID: mdl-28009206

ABSTRACT

The possible exotic meson Z_{c}(3900), found in e^{+}e^{-} reactions, is studied by the method of coupled-channel scattering in lattice QCD. The interactions among πJ/ψ, ρη_{c}, and D[over ¯]D^{*} channels are derived from (2+1)-flavor QCD simulations at m_{π}=410-700 MeV. The interactions are dominated by the off-diagonal πJ/ψ-D[over ¯]D^{*} and ρη_{c}-D[over ¯]D^{*} couplings, which indicates that the Z_{c}(3900) is not a usual resonance but a threshold cusp. Semiphenomenological analyses with the coupled-channel interaction are also presented to confirm this conclusion.

16.
Int J Pharm ; 514(1): 121-132, 2016 Nov 30.
Article in English | MEDLINE | ID: mdl-27863655

ABSTRACT

Here we examine the mechanisms by which nanoparticles enable the oral absorption of water-insoluble, P-glycoprotein efflux pump (P-gp) substrates, without recourse to P-gp inhibitors. Both 200nm paclitaxel N-(2-phenoxyacetyl)-6-O-glycolchitosan (GCPh) nanoparticles (GCPh-PTX) and a simulated Taxol formulation, facilitate drug dissolution in biorelevant media, unlike paclitaxel nanocrystals. Verapamil (40mgkg-1) increased the oral absorption from low dose Taxol (6 or 10mgkg-1) by 100%, whereas the oral absorption from high dose Taxol (20mgkg-1) or low dose GCPh-PTX (6 or 10mgkg-1) was largely unchanged by verapamil. There was virtually no absorption from control paclitaxel nanocrystals (20mgkg-1). Imaging of ex-vivo rat ileum samples showed that fluorescently labelled GCPh nanoparticles are mucoadhesive and are taken up by ileum epithelial cells. GCPh nanoparticles were also found to open Caco-2 cell tight junctions. In conclusion, mucoadhesive, drug solubilising GCPh nanoparticles enable the oral absorption of paclitaxel via the saturation of the P-gp pump (by high local drug concentrations) and by particle uptake and tight junction opening mechanisms.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , Nanoparticles/chemistry , Nanoparticles/metabolism , Water/chemistry , Administration, Oral , Animals , Biological Transport/drug effects , Caco-2 Cells , Cell Line, Tumor , Chitosan/chemistry , Chitosan/metabolism , Drug Carriers/chemistry , Drug Carriers/metabolism , Epithelial Cells/metabolism , Humans , Ileum/metabolism , Intestinal Absorption/drug effects , Male , Mice , Paclitaxel/chemistry , Paclitaxel/metabolism , Rats , Rats, Wistar , Solubility , Tight Junctions/metabolism , Verapamil/chemistry , Verapamil/metabolism
17.
Metab Eng ; 29: 76-85, 2015 May.
Article in English | MEDLINE | ID: mdl-25769289

ABSTRACT

As a means to improve carbon uptake in the cyanobacterium Synechocystis sp. strain PCC6803, we engineered strains to contain additional inducible copies of the endogenous bicarbonate transporter BicA, an essential component of the CO2-concentrating mechanism in cyanobacteria. When cultured under atmospheric CO2 pressure, the strain expressing extra BicA transporters (BicA(+) strain) grew almost twice as fast and accumulated almost twice as much biomass as the control strain. When enriched with 0.5% or 5% CO2, the BicA(+) strain grew slower than the control but still showed a superior biomass production. Introducing a point mutation in the large C-terminal cytosolic domain of the inserted BicA, at a site implicated in allosteric regulation of transport activity, resulted in a strain (BicA(+)(T485G) strain) that exhibited pronounced cell aggregation and failed to grow at 5% CO2. However, the bicarbonate uptake capacity of the induced BicA(+)(T485G) was twice higher than for the wild-type strain. Metabolic analyses, including phenotyping by synchrotron-radiation Fourier transform Infrared spectromicroscopy, scanning electron microscopy, and lectin staining, suggest that the excess assimilated carbon in BicA(+) and BicA(+)(T485G) cells was directed into production of saccharide-rich exopolymeric substances. We propose that the increased capacity for CO2 uptake in the BicA(+) strain can be capitalized on by re-directing carbon flux from exopolymeric substances to other end products such as fuels or high-value chemicals.


Subject(s)
Anion Transport Proteins , Bacterial Proteins , Biomass , Gene Dosage , Synechocystis , Anion Transport Proteins/biosynthesis , Anion Transport Proteins/genetics , Bacterial Proteins/biosynthesis , Bacterial Proteins/genetics , Bicarbonates/metabolism , Ion Transport/genetics , Synechocystis/genetics , Synechocystis/growth & development
18.
Gan To Kagaku Ryoho ; 41(3): 395-7, 2014 Mar.
Article in Japanese | MEDLINE | ID: mdl-24743292

ABSTRACT

A 72-year-old woman was admitted to our hospital with bloody stools and constipation. She was diagnosed with advanced lower rectal cancer with multiple liver and pulmonary metastases. Because the rectal cancer was located 2 cm from the anal verge, we suggested she undergo an abdominoperineal resection(Miles operation), but she refused to undergo a colostomy. Then, 6 courses of chemotherapy with S-1/oxaliplatin(SOX)were administered, and the local tumor, liver metastases, and pulmonary metastases were all significantly decreased in size(reduction rate 60%). After chemotherapy, she chose to undergo low anterior resection(LAR), D2. Postoperative recovery was uneventful, and she currently has stable disease with adjuvant SOX chemotherapy. Induction SOX chemotherapy was considered to be useful for maintaining the quality of life(QOL) in a patient with advanced rectal cancer.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Rectal Neoplasms/drug therapy , Aged , Chemotherapy, Adjuvant , Colostomy , Drug Combinations , Female , Humans , Liver Neoplasms/drug therapy , Liver Neoplasms/secondary , Lung Neoplasms/drug therapy , Lung Neoplasms/secondary , Neoplasm Staging , Organoplatinum Compounds/administration & dosage , Oxaliplatin , Oxonic Acid/administration & dosage , Rectal Neoplasms/pathology , Rectal Neoplasms/surgery , Tegafur/administration & dosage , Treatment Outcome
19.
Recent Pat Antiinfect Drug Discov ; 8(3): 198-205, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24320230

ABSTRACT

Each year in the United States, at least 2 million people become infected with bacteria that are resistant to antibiotics and at least 23,000 people die each year as a direct result of these infections (Threat report 2013). Vancomycin is an FDA approved antibiotic and is growing importance in the treatment of hospital infections, with particular emphasis on its value to fight against methicillin-resistant Staphylococcus aureus (MRSA). The increasing use of vancomycin to treat infections caused by the Gram-positive MRSA in the 1970s selected for drug-resistant enterococci, less potent than staphylococci but opportunistic in the space vacated by other bacteria and in patients with compromised immune systems. The dramatic rise of antibiotic-resistant bacteria over the past two decades has stressed the need for completely novel classes of antibacterial agents. This paper reports the recent patent review on the strategy for finding novel quercetinglycoside type antibacterial agents against vancomycin-resistant bacterial strains.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Glycosides/therapeutic use , Gram-Positive Bacterial Infections/drug therapy , Methicillin-Resistant Staphylococcus aureus , Patents as Topic , Quercetin/therapeutic use , Staphylococcal Infections/drug therapy , Vancomycin-Resistant Enterococci , Vancomycin/therapeutic use , Humans
20.
Phys Rev Lett ; 111(11): 112503, 2013 Sep 13.
Article in English | MEDLINE | ID: mdl-24074080

ABSTRACT

Quark mass dependence of the equation of state (EOS) for nucleonic matter is investigated, on the basis of the Brueckner-Hartree-Fock method with the nucleon-nucleon interaction extracted from lattice QCD simulations. We observe saturation of nuclear matter at the lightest available quark mass corresponding to the pseudoscalar meson mass ≃469 MeV. Mass-radius relation of the neutron stars is also studied with the EOS for neutron-star matter from the same nuclear force in lattice QCD. We observe that the EOS becomes stiffer and thus the maximum mass of neutron star increases as the quark mass decreases toward the physical point.


Subject(s)
Elementary Particles , Models, Theoretical , Neutrons , Nuclear Physics/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...